Research trial to prevent onset of Type 1 Diabetes

LOUISVILLE, KY (WAVE)-  UofL pediatric endrocrinologist Kupper Wintergerst and his TrialNet team will begin screening for antibodies that cause diabetes and enrolling participants into TrialNet.  UofL Pediatrics is one of 150 affiliated sites and the only pediatric TrialNet site in Kentucky.

More than 5,000 people are expected to attend the JDRF Walk. Many will be eligible for a free blood test to determine whether they are at risk for diabetes and whether they may participate in TrialNet studies, including those that use medications to delay or prevent the disease.

TrialNet is an international network of researchers exploring ways to prevent, delay and reverse the progression of type 1 diabetes mellitus.

The 2011 Juvenile Diabetes Research Foundation Walk is Saturday at Churchill Downs Infield.  Registration begins at 11 a.m. The walk begins at 12:30 p.m.   Blood draws will occur throughout the event—before, during and after the walk.

Type 1 diabetes is an autoimmune disease that affects the body's ability to produce the hormone insulin which leads to high blood sugar. Abnormal blood sugar levels can cause blindness, kidney failure, heart disease, stroke and death.